Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet
Journal Title: Annals of Hepatology - Year 2011, Vol 10, Issue 4
Abstract
Objective. To evaluate the efficacy of low carbohydrate diet (LCD) as compared with low fat diet (LFD) to decrease aminotransferase levels in obese women with nonalcoholic fatty liver disease. Material and methods. A total of 59 women were randomly enrolled in a non-controlled clinical intervention study to receive either LCD or LFD during six months. Apparently healthy non-pregnant obese women aged 20 to 65 years were eligible to participate. Previous diagnosis of hepatic disease, serum creatinine level ≥ 1.5 mg/dL, severe life-limiting medical illness, pregnancy, active participation in other dietary program, use of weight loss drugs, or alcohol consumption ≥ 30 g per day were exclusion criteria. Results. A total of 31 obese women who received LCD were compared with 28 women allocated in the LFD group. There were 3 (LCD group) and 2 (LFD group) women with lost of follow-up. No differences in the proportion of type 2 diabetes, hypertension and hyperlipidemia were noted between women in the LCD and LFD groups. At end of follow-up, there were not significant statistical differences in the anthropometric and biochemical characteristics between women in both groups. The weight loss was 5.7 and 5.5% for women in the LCD LFD groups. Although the decrease of AST (31.7 and 22.4%) and ALT (41 and 33.3%) levels was more elevated in the women of LCD group, as compared with the LFD group, there were not significant statistical differences. Conclusions. Our results show that weight loss, irrespective of the type of diet, reduces aminotransferase levels in obese women with NAFLD.
Authors and Affiliations
Heriberto Rodríguez-Hernández, Miriam Cervantes-Huerta, Martha Rodríguez-Moran, Fernando Guerrero-Romero
Keywords
Related Articles
- EP ID EP78080
- DOI -
- Views 138
- Downloads 0
Hepatoblastoma. Clinical experience at a single institution using the Siopel staging system.
Background. Staging in Hepatoblastoma has recently become controversial. In developing countries diagnosis occurs mostly in advanced stages under these circumstances, we propose another option that can be considered of p...
IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis
[b]Background[/b]. IGF-I and IGFBP-3 are part of IGF system and, due to their predominantly hepatic synthesis, they seem to correlate with hepatic dysfunction intensity. Aims. To investigate the significance of IGF-I and...
Cytokines as important playmakers of experimental hepatocarcinogenesis confounded by diabetes
Purpose. To explore the possible intermediary pathways through which diabetes mellitus (DM) adversely worsens hepatocellular carcinoma (HCC), focusing on cell life controllers as some transcription factors and inflammato...
Lightbulbs of the biliary tree: A radiological finding in Christmas time
Autoimmune hepatitis with giant-cell transformation
Background/Aims: Giant-cell hepatitis (GCH), also known as postinfantile or syncytial giant cell hepatitis, is a frequent pattern of liver injury in the neonate, primarily seen in the first three months of life. Few case...